Your browser doesn't support javascript.
loading
Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome.
Greenbaum, Larry A; Fila, Marc; Ardissino, Gianluigi; Al-Akash, Samhar I; Evans, Jonathan; Henning, Paul; Lieberman, Kenneth V; Maringhini, Silvio; Pape, Lars; Rees, Lesley; van de Kar, Nicole C A J; Vande Walle, Johan; Ogawa, Masayo; Bedrosian, Camille L; Licht, Christoph.
Afiliación
  • Greenbaum LA; Emory University and Children's Healthcare of Atlanta, Atlanta, Georgia, USA. Electronic address: lgreen6@emory.edu.
  • Fila M; CHRU de Montpellier - Hôpital Arnaud de Villeneuve, Montpellier, France.
  • Ardissino G; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Al-Akash SI; Driscoll Children's Hospital, Corpus Christi, Texas, USA.
  • Evans J; Nottingham University Hospitals, Nottingham, United Kingdom.
  • Henning P; Women's and Children's Hospital, North Adelaide, South Australia, Australia.
  • Lieberman KV; Hackensack University Medical Center, Hackensack, New Jersey, USA.
  • Maringhini S; G. Di Cristina Children's Hospital, Palermo, Italy.
  • Pape L; Hannover Medical School, Hannover, Germany.
  • Rees L; Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.
  • van de Kar NC; Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Vande Walle J; University Hospital Ghent, Ghent, Belgium.
  • Ogawa M; Alexion Pharmaceuticals, Inc., Cheshire, Connecticut, USA.
  • Bedrosian CL; Alexion Pharmaceuticals, Inc., Cheshire, Connecticut, USA.
  • Licht C; The Hospital for Sick Children, Toronto, Ontario, Canada.
Kidney Int ; 89(3): 701-11, 2016 Mar.
Article en En | MEDLINE | ID: mdl-26880462

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Activación de Complemento / Inactivadores del Complemento / Anticuerpos Monoclonales Humanizados / Síndrome Hemolítico Urémico Atípico Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: America do norte / Europa / Oceania Idioma: En Revista: Kidney Int Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Activación de Complemento / Inactivadores del Complemento / Anticuerpos Monoclonales Humanizados / Síndrome Hemolítico Urémico Atípico Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: America do norte / Europa / Oceania Idioma: En Revista: Kidney Int Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos